That is why I stopped the ART: Patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme

被引:106
作者
Dahab, Mison [1 ,2 ,3 ]
Charalambous, Salome [2 ]
Hamilton, Robin [2 ]
Fielding, Katherine [4 ]
Kielmann, Karina [5 ]
Churchyard, Gavin J. [1 ,2 ,4 ]
Grant, Alison D. [1 ]
机构
[1] London Sch Hyg & Trop Med, Dept Infect & Trop Med, Clin Res Unit, London WC1E 7HT, England
[2] Aurum Inst Hlth Res, Johannesburg, South Africa
[3] Univ KwaZulu Natal, Collaborat Programme AIDS Res S Africa, Durban, South Africa
[4] London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth, Infect Dis & Epidemiol Unit, London WC1, England
[5] London Sch Hyg & Trop Med, Dept Publ Hlth Policy, Hlth Policy Unit, London WC1, England
基金
英国医学研究理事会;
关键词
D O I
10.1186/1471-2458-8-63
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: As ART programmes in African settings expand beyond the pilot stages, adherence to treatment may become an increasing challenge. This qualitative study examines potential barriers to, and facilitators of, adherence to ART in a workplace programme in South Africa. Methods: We conducted key informant interviews with 12 participants: six ART patients, five health service providers (HSPs) and one human resources manager. Results: The main reported barriers were denial of existence of HIV or of one's own positive status, use of traditional medicines, speaking a different language from the HSP, alcohol use, being away from home, perceived severity of side-effects, feeling better on treatment and long waiting times at the clinic. The key facilitators were social support, belief in the value of treatment, belief in the importance of one's own life to the survival of one's family, and the ability to fit ART into daily life schedules. Conclusion: Given the reported uncertainty about the existence of HIV disease and the use of traditional medicines while on ART, despite a programme emphasising ART counselling, there is a need to find effective ways to support adherence to ART even if the individual does not accept biomedical concepts of HIV disease or decides to use traditional medicines. Additionally, providers should identify ways to minimize barriers in communication with patients with whom they have no common language. Finally, dissatisfaction with clinical services, due to long waiting times, should be addressed.
引用
收藏
页数:6
相关论文
共 28 条
[1]  
Babb Dale A, 2007, Psychol Health Med, V12, P314, DOI 10.1080/13548500600621511
[2]   Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[3]   Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness [J].
Bangsberg, DR ;
Acosta, EP ;
Gupta, R ;
Guzman, D ;
Riley, ED ;
Harrigan, PR ;
Parkin, N ;
Deeks, SG .
AIDS, 2006, 20 (02) :223-231
[4]   Adherence to HIV antiretroviral therapy in HIV plus Ugandan patients purchasing therapy [J].
Byakika-Tusiime, J ;
Oyugi, JH ;
Tumwikirize, WA ;
Katabira, ET ;
Mugyenyi, PN ;
Bangsberg, DR .
INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (01) :38-41
[5]  
DAHAB M, 2006, QUANTITATIVE STUDY B
[6]  
Carvalho Cláudio Viveiros de, 2003, Cad. Saúde Pública, V19, P593, DOI 10.1590/S0102-311X2003000200026
[7]  
Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386
[8]  
Green J., 2004, QUALITATIVE METHODS, P262
[9]   The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response [J].
Haubrich, RH ;
Little, SJ ;
Currier, JS ;
Forthal, DN ;
Kemper, CA ;
Beall, GN ;
Johnson, D ;
Dubé, MP ;
Hwang, JY ;
McCutchan, JA .
AIDS, 1999, 13 (09) :1099-1107
[10]   Adherence in AIDS clinical trials: A framework for clinical research and clinical care [J].
Ickovics, JR ;
Meisler, AW .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (04) :385-391